On-Body Delivery System enFuse Saves Time, Improves QOL for Patients
An on-body delivery system approved last fall for paroxysmal nocturnal hemoglobinuria (PNH) has seen rapid uptake and is now being studied for use with isatuximab.
Source: ajmc.com